A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague

Two doses of the vaccine provided complete protection against both inhalational anthrax and pneumonic plague in animal models. Further, results establish the T4 nanoparticle as a novel platform to develop multivalent vaccines against pathogens of high public health significance.